PE74699A1 - Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento del trauma del sistema nervioso central - Google Patents
Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento del trauma del sistema nervioso centralInfo
- Publication number
- PE74699A1 PE74699A1 PE1998000386A PE00038698A PE74699A1 PE 74699 A1 PE74699 A1 PE 74699A1 PE 1998000386 A PE1998000386 A PE 1998000386A PE 00038698 A PE00038698 A PE 00038698A PE 74699 A1 PE74699 A1 PE 74699A1
- Authority
- PE
- Peru
- Prior art keywords
- molecular weight
- low molecular
- heparines
- trauma
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
SE REFIERE A HEPARINAS DE BAJO PESO MOLECULAR COMPRENDIDO ENTRE 1000 Y 10000 DALTONS EN PARTICULAR ENTRE 4000 Y 5000 DALTONS. LA HEPARINA ESTA CONSTITUIDA POR OLIGOSACARIDOS QUE TIENEN UN ACIDO 2-O-SULFO-4-ENOPIRANOSURONICO EN UNO DE SUS EXTREMOS. SE OBTIENE LA HEPARINA POR DESPOLIMERIZADO DE UN ESTER DE HEPARINA POR MEDIO DE UNA BASE COMO LA SOSA. LA HEPARINA DE BAJO PESO MOLECULAR ES LA ENOXAPARINA, NADROPARINA, PARNAPARINA, REVIPARINA, ENTRE OTRAS; LAS QUE PUEDEN SER UTILES PARA LA PREVENCION Y EL TRATAMIENTO DEL TRAUMA DEL SISTEMA NERVIOSO CENTRAL, PRINCIPALMENTE DEL TRAUMATISMO ESPINAL, CRANEAL O CRANEO-ESPINAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9706550A FR2763848B1 (fr) | 1997-05-28 | 1997-05-28 | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE74699A1 true PE74699A1 (es) | 1999-10-21 |
Family
ID=9507335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000386A PE74699A1 (es) | 1997-05-28 | 1998-05-19 | Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento del trauma del sistema nervioso central |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6380173B1 (es) |
| EP (2) | EP1421943A1 (es) |
| JP (1) | JP2002500660A (es) |
| KR (1) | KR100531721B1 (es) |
| CN (1) | CN1212845C (es) |
| AR (1) | AR012876A1 (es) |
| AT (1) | ATE276752T1 (es) |
| AU (1) | AU752322B2 (es) |
| BR (1) | BR9809504A (es) |
| CA (1) | CA2290675A1 (es) |
| DE (1) | DE69826460T2 (es) |
| ES (1) | ES2227841T3 (es) |
| FR (1) | FR2763848B1 (es) |
| IL (2) | IL132671A0 (es) |
| MA (1) | MA24553A1 (es) |
| NO (1) | NO317517B1 (es) |
| NZ (1) | NZ501365A (es) |
| PE (1) | PE74699A1 (es) |
| PT (1) | PT984786E (es) |
| RU (1) | RU2215531C2 (es) |
| TN (1) | TNSN98071A1 (es) |
| TW (1) | TW533075B (es) |
| WO (1) | WO1998053833A1 (es) |
| ZA (1) | ZA984432B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010041686A1 (en) * | 2000-01-06 | 2001-11-15 | Veronique Mary | Novel therapeutic application of enoxaparin |
| ITMI20012599A1 (it) * | 2001-12-11 | 2003-06-11 | Cosmo Spa | Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int |
| US9308220B2 (en) | 2001-12-11 | 2016-04-12 | Cosmo Technologies Limited | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| US7511026B2 (en) | 2003-03-25 | 2009-03-31 | Seikagaku Corporation | Therapeutic agent for nerve damage |
| ITMI20031023A1 (it) * | 2003-05-21 | 2004-11-22 | Umberto Cornelli | Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA829463B (en) * | 1982-07-19 | 1983-10-26 | Hepar Ind Inc | Process for manufacturing low molecular weight heparins by depolymerization of normal heparin |
| FR2614026B1 (fr) * | 1987-04-16 | 1992-04-17 | Sanofi Sa | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
| IT1243300B (it) * | 1990-12-20 | 1994-05-26 | Fidia Spa | Derivati dell'eparina |
| IT1264530B (it) * | 1992-07-31 | 1996-10-02 | Crinos Industria Farmaco | Impiego dei polisaccaridi nelle neuropatie atrofico degenerative |
-
1997
- 1997-05-28 FR FR9706550A patent/FR2763848B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-19 PE PE1998000386A patent/PE74699A1/es not_active Application Discontinuation
- 1998-05-25 MA MA25088A patent/MA24553A1/fr unknown
- 1998-05-25 BR BR9809504-8A patent/BR9809504A/pt not_active Application Discontinuation
- 1998-05-25 RU RU99128105/14A patent/RU2215531C2/ru not_active IP Right Cessation
- 1998-05-25 AU AU77759/98A patent/AU752322B2/en not_active Ceased
- 1998-05-25 AT AT98925773T patent/ATE276752T1/de not_active IP Right Cessation
- 1998-05-25 KR KR10-1999-7010960A patent/KR100531721B1/ko not_active IP Right Cessation
- 1998-05-25 DE DE69826460T patent/DE69826460T2/de not_active Expired - Lifetime
- 1998-05-25 CN CNB988054892A patent/CN1212845C/zh not_active Expired - Fee Related
- 1998-05-25 NZ NZ501365A patent/NZ501365A/xx unknown
- 1998-05-25 EP EP04003133A patent/EP1421943A1/fr not_active Withdrawn
- 1998-05-25 PT PT98925773T patent/PT984786E/pt unknown
- 1998-05-25 TW TW087108065A patent/TW533075B/zh not_active IP Right Cessation
- 1998-05-25 WO PCT/FR1998/001034 patent/WO1998053833A1/fr active IP Right Grant
- 1998-05-25 CA CA002290675A patent/CA2290675A1/fr not_active Abandoned
- 1998-05-25 IL IL13267198A patent/IL132671A0/xx active IP Right Grant
- 1998-05-25 ZA ZA984432A patent/ZA984432B/xx unknown
- 1998-05-25 EP EP98925773A patent/EP0984786B1/fr not_active Expired - Lifetime
- 1998-05-25 ES ES98925773T patent/ES2227841T3/es not_active Expired - Lifetime
- 1998-05-25 JP JP50031099A patent/JP2002500660A/ja not_active Ceased
- 1998-05-27 TN TNTNSN98071A patent/TNSN98071A1/fr unknown
- 1998-05-27 AR ARP980102470A patent/AR012876A1/es unknown
-
1999
- 1999-11-01 IL IL132671A patent/IL132671A/en not_active IP Right Cessation
- 1999-11-12 NO NO19995538A patent/NO317517B1/no not_active IP Right Cessation
- 1999-11-24 US US09/448,244 patent/US6380173B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| BR9809504A (pt) | 2000-06-20 |
| MA24553A1 (fr) | 1998-12-31 |
| KR100531721B1 (ko) | 2005-11-28 |
| EP1421943A1 (fr) | 2004-05-26 |
| NO317517B1 (no) | 2004-11-08 |
| EP0984786A1 (fr) | 2000-03-15 |
| CN1212845C (zh) | 2005-08-03 |
| FR2763848B1 (fr) | 2000-01-28 |
| KR20010012988A (ko) | 2001-02-26 |
| DE69826460T2 (de) | 2005-10-13 |
| IL132671A0 (en) | 2001-03-19 |
| JP2002500660A (ja) | 2002-01-08 |
| CN1257428A (zh) | 2000-06-21 |
| EP0984786B1 (fr) | 2004-09-22 |
| TW533075B (en) | 2003-05-21 |
| NZ501365A (en) | 2002-12-20 |
| WO1998053833A1 (fr) | 1998-12-03 |
| AU7775998A (en) | 1998-12-30 |
| NO995538D0 (no) | 1999-11-12 |
| TNSN98071A1 (fr) | 2005-03-15 |
| ZA984432B (en) | 1998-12-02 |
| NO995538L (no) | 1999-11-12 |
| ES2227841T3 (es) | 2005-04-01 |
| RU2215531C2 (ru) | 2003-11-10 |
| DE69826460D1 (de) | 2004-10-28 |
| AR012876A1 (es) | 2000-11-22 |
| ATE276752T1 (de) | 2004-10-15 |
| IL132671A (en) | 2007-06-17 |
| PT984786E (pt) | 2005-01-31 |
| FR2763848A1 (fr) | 1998-12-04 |
| US6380173B1 (en) | 2002-04-30 |
| AU752322B2 (en) | 2002-09-19 |
| CA2290675A1 (fr) | 1998-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5091171B2 (en) | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use | |
| ES2159769T3 (es) | Polimero en bloque lineal que comprende grupos urea y uretano, procedimiento para producirlo y su utilizacion en forma de implantes. | |
| ES2130268T3 (es) | Preparados de acido hialuronico de bajo peso molecular, para estimulacion de formacion de huesos. | |
| MX167917B (es) | Nuevos materiales y dispositivos quirurgicos | |
| IT1306679B1 (it) | Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della | |
| ITPD910229A1 (it) | Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico | |
| BR0007487A (pt) | Difenil-uréias substituìdas com w-carbóxi-arilas como inibidores de raf cinase | |
| PT871473E (pt) | Utilizacao de il-10 para curar feridas com cicatrizacao reduzida | |
| BR8802492A (pt) | Composicao esterilizante e de alto grau desinfetante,inodora | |
| HK1106161A1 (en) | Amide derivatives of hyaluronic acid in osteoarthrosis | |
| PE74699A1 (es) | Utilizacion de las heparinas de bajo peso molecular para la prevencion y el tratamiento del trauma del sistema nervioso central | |
| ES2066152T3 (es) | Composiciones que contienen derivados de la quitina para impedir la adhesion. | |
| ES2159403T3 (es) | Poliuretanos termoplasticos que contienen principios activos. | |
| BR9812298A (pt) | Polìmeros lineares enxertados com siliconeenrigecido | |
| ES2180514T3 (es) | Uso de un factor con actividad inhibidora del melanoma (mia) para reparacion de cartilagos y huesos. | |
| BR9810693A (pt) | Composição bioativa moldável, composição farmacêutica biocompatìvel, e, processos para reparo, substituição, reconfiguração, reconstrução ou aumento de estruturas anatÈmicas de tecido duro e para induzir osteogênese | |
| ECSP003707A (es) | Diazepanes | |
| ES2195000T3 (es) | Composicion farmaceutica. | |
| DK1152757T3 (da) | MMP-inhibitorer i bindevævsblödhed | |
| BR9808066A (pt) | Dispositivo e kit para a estimulação da regeneração nervosa, utilização de uma luva biocompatìvel e produto para a liberação local e prolongada de uma substância neurotrófica | |
| ES2133734T3 (es) | Formulaciones farmaceuticas que comprenden una politiourea y procedimiento de utilizacion correspondiente. | |
| ZA92603B (en) | Low molecular weight sulfated poly-beta-2,6-fructofuranosans and the use thereof for the treatment of degenerative joint disorders | |
| AR026756A1 (es) | Nuevas combinaciones terapeuticas (s)-2-bencilamino-metil)-2,3,8,9-tetrahidro-7h-1,4-dioxino[2,3-e]indol-8-ona y neuroleticos para el tratamiento oprevencion de desordenes psicoticos | |
| SE9904066D0 (sv) | Steril, icke-antigen hyaluronsyralösning och användning därav | |
| MD1346G2 (ro) | Aparat pentru repoziţia şi fixarea eschilelor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |